The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The global Pompe disease market is on the cusp of significant growth, with expectations of expanding from $1.56 billion in 2022 to $1.66 billion in 2023, representing a notable compound annual growth rate (CAGR) of 6.3%. Looking ahead, the market is projected to reach $1.99 billion by 2027, with a CAGR of 4.5%. In this blog, we will explore the factors fueling this market’s growth, major players, and the emerging trend of product innovations.

A Rare Yet Growing Concern
Before we delve into the dynamics of the Pompe disease market, it’s essential to understand this rare genetic disorder. Pompe disease, also known as glycogen storage disease type II or acid maltase deficiency, is characterized by the accumulation of glycogen in various body tissues, particularly muscles and organs. Its treatments include protein replacement therapy, alglucosidase alfa, and Nexviazyme for intravenous infusion. The growth of this market is closely tied to the increase in Pompe disease cases.

For instance, according to the European Medicines Agency Highlights in June 2022, Europe had approximately 224 infantile-onset, 471 juvenile-onset, and 20,490 adult-onset individuals with mutations that potentially cause Pompe disease, based on the maximum birth incidence of 11.6 per 100,000. These figures underscore the growing prevalence of Pompe disease, which is a significant driver of market growth.

Key Players in the Pompe Disease Market
Leading the charge in the Pompe disease market are prominent players committed to addressing the needs of those affected by this rare genetic disorder. Major companies in the market include:

• F. Hoffmann-La Roche AG
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Thermo Fisher Scientific Inc.
• Fresenius Kabi AG
• Danaher Corporation
• Becton, Dickinson and Company
• Astellas Pharma Inc.
• BioMérieux SA
• BioMarin Pharmaceutical Inc.
• Nova Biomedical Corporation
• Instrumentation Laboratory Company

These market leaders play a pivotal role in advancing treatments and therapies for Pompe disease, driving the market’s growth.

Innovations in Pompe Disease Therapies
Product innovations have become a noteworthy trend in the Pompe disease market. Major companies are actively pursuing innovation to enhance their market position and deliver more effective treatments. A recent example of this trend is Amicus Therapeutics’ announcement in March 2023 regarding Pombiliti, an enzyme replacement therapy (ERT). The European Commission approved this product as a long-term enzyme substitution treatment, meant to be used in combination with Miglustat, an oral enzyme stabilizer. Pombiliti is designed for all adults living with late-onset Pompe disease and has shown substantial improvements in muscle, joint, and respiratory measures during research trials.

Pompe Disease Market Segmentation:

The Pompe disease market offers various segmentation options to address the diverse requirements of patients and healthcare providers:

1) By Type:

• Classic Infantile Form
• Non-Classic Infantile Form
• Late-Onset Form
• Other Types

2) By Diagnosis:

• Blood Test
• Genetic Test
• Prenatal Test
• Other Diagnosis

3) By Route of Administration:

• Oral
• Parenteral
• Other Routes of Administration

4) By Therapy Type:

• Enzyme Replacement Therapy (ERT)
• Substrate Reduction Therapy (SRT)
• Gene Therapy
• Other Therapies

5) By End Users:

• Hospitals / Clinics
• Pharmaceuticals
• Researchers
• Other End-Users

Global and Regional Dynamics
In 2022, North America was the largest region in the Pompe disease market, reflecting the region’s prominent role in this field. However, as the market grows, it is expected to expand globally, with diverse regions contributing to its development.

Read More On The Pompe Disease Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Request for A Sample Of The Global Pompe Disease Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=11906&type=smp

The Table Of Content For The Pompe Disease Market Include:
1. Pompe Disease Market Executive Summary
2. Pompe Disease Market Segments
3. Pompe Disease Market Size And Pompe Disease Market Growth Rate
4. Key Pompe Disease Market Trends
5. Major Pompe Disease Market Drivers
……
25. Key Mergers And Acquisitions In The Pompe Disease Market
26. Top Pompe Disease Companies
27. Pompe Disease Market Opportunities And Strategies
28. Pompe Disease Market, Conclusions And Recommendations
29. Appendix

The Pompe Disease Market Global Market Report 2023 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the pompe disease market.

View More Reports Related To The Market –
Preventive Healthcare Technologies And Services Global Market Report 2023
Healthcare Interoprability Solutions Global Market Report 2023
Precision Medicine Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model